3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Melanoma
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Breast Neoplasms
1
Interventions
TP protocol
2
pembrolizumab
1
cabozantinib
1
Technetium
1
Surgical Procedures, Operative
1
Specimen Handling
1
Radiotherapy, Adjuvant
1
Radiotherapy
1
Paclitaxel
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Indocyanine Green
1
Control Groups
1
Cobalt-60
1
Cisplatin
1
Chemotherapy, Adjuvant
1
Chemoradiotherapy
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Lymphatic Metastasis
×
Technetium
×
Clear all
NCT04233476
2024-07-01
TRIIL
RDO Pharm.
Phase 3
Completed
409 enrolled